Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: Germany Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20154
20163
20177
20185
20199
202012
202110
202218
202313
202412
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting98

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca16
Eli Lilly and Company7
Janssen Research & Development, LLC7
Hoffmann-La Roche6
Merck Sharp & Dohme LLC6
Novartis Pharmaceuticals5
Bristol-Myers Squibb3
Daiichi Sankyo3
EMD Serono Research & Development Institute, Inc.3
Gilead Sciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung98
Lung Neoplasms13
Colorectal Neoplasms10
Neoplasm Metastasis8
Neoplasms8
Melanoma7
Head and Neck Neoplasms6
Ovarian Neoplasms6
Colonic Neoplasms5
Pancreatic Neoplasms5

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.